Transcription factors: Potential roles in drug-induced neuroplasticity

Reviews in the Neurosciences

Volumn 7, Issue 4, 1996, Pages 233-275

  Persico, Antonio M ^a   Uhl, George R ^b,c  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Addiction; c fos; Craving; Immediate early gene; Sensitization; Tolerance; Transcription factor; Withdrawal

Indexed keywords

GROWTH FACTOR; PSYCHOSTIMULANT AGENT; TRANSCRIPTION FACTOR;

DRUG DEPENDENCE; DRUG TOLERANCE; DRUG WITHDRAWAL; GENE EXPRESSION; GENE INDUCTION; HOUSEKEEPING GENE; HUMAN; IMMEDIATE EARLY GENE; NERVE CELL PLASTICITY; NUCLEIC ACID PROBE; ONCOGENE C FOS; OPIATE ADDICTION; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; STRUCTURE ACTIVITY RELATION; TRANSCRIPTION REGULATION; TRANSLATION REGULATION;

EID: 0030453486     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.1996.7.4.233     Document Type: Review

References (330)

1. Abate C, Patel L, Rauscher III FJ, Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 1990; 249: 1157-1161.
2. Abate C, Baker SJ, Lees-Miller SP, Anderson CW, Marshak DR, Curran T. Dimerization and DNA binding alter phosphorylation of Fos and Jun. Proc Natl Acad Sci USA 1993; 90: 6766-6770.
3. Adler V, Polotskaya A, Wagner F. Kraft AS. Affinity-purified c-Jun amino-terminal protein kinase requires serine/treonine phosphorylation for activity. J Biol Chem 1992; 267: 17001-17005.
4. Alcantara AA, Greenough WT. Developmental regulation of Fos and Fos-Related Antigens in cerebral cortex, striatum, hippocampus, and cerebellum of the rat. J Comp Neurol 1993; 334: 75-85.
5. Angel P, Allegretto EA, Okino ST, Hattori K, Boyle WJ, Hunter T, Karin M. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1. Nature 1988; 332: 166-171.
6. Angel P, Hattori K, Smeal T, Karin M. The jun proto-oncogene is positively auto regulated by its product, Jun/AP1. Cell 1988; 55: 875-885.
7. Armstrong RC, Montminy MR. Transsynaptic control of gene expression. Ann Rev Neurosci 1993; 16: 17-29.
8. Asanuma M, Ogawa N, Hirata H, Chou H, Tanaka K, Mori A. Opposite effects of rough and gentle handling with repeated saline administration on c-fos mRNA expression in the rat brain. J Neural Transm 1992; 90: 163-169.
9. Asin KE, Nikkel AL, Wirtshafter D. Repeated D1 receptor agonist treatment blocks cocaine-induced locomotor activity and c-fos expression. Brain Res 1994; 637: 342-344.
10. Atwater JA, Wisdom R, Verma IM. Regulated mRNA stability. Ann Rev Genet 1990; 24: 519-541.
11. Bading H, Ginty DD, Greenberg ME. Regulation of gene expression in hippocampal neurons by distinct calcium signaling pathways. Science 1993; 260: 181-186.
12. Baker SJ, Kerppola TK, Luk D, Vandenberg MT, Marshak DR, Curran T, Abate C. Jun is phosphorylated by several protein kinases at the same sites that are modified in serum-stimulated fibroblasts. Mol Cell Biol 1992; 12: 4694-4705.
13. Baxter LR Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry 1989; 46: 243-250.
14. Beck CHM, Fibiger HC. Conditioned fear-induced changes in behavior and in the expression of the immediate early gene c-fos: with and without diazepam pretreatment. J Neurosci 1995: 15: 709-720.
15. Bergold PJ, Sweatt JD, Winicov I, Weiss KR, Kandel ER, Schwartz JH. Protein synthesis during acquisition of long-term facilitation is needed for the persistent loss of regulatory subunits of the Aplysia cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1990; 87: 3788-3791.
16. Best JA, Chen Y, Piech KM, Tank AW. The response of the tyrosine hydroxylase gene to cyclic AMP is mediated by two cyclic AMP-response elements. J Neurochem 1995; 65: 1934-1943.
17. Bhat RV, Cole AJ, Baraban JM. Chronic cocaine treatment suppresses basal expression of zif268 in rat forebrain: in situ hybridization studies. J Pharmacol Exp Ther 1992; 263: 343-349.
18. Bhat RV, Worley PF, Cole AJ, Baraban JM. Activation of the zinc finger encoding gene krox-20 in adult rat brain: comparison with zif268. Mol Brain Res 1992; 13: 263-266.
19. Bhat RV, Baraban JM. Activation of transcription factor genes in striatum by cocaine: role of both serotonin and dopamine systems. J Pharmacol Exp Ther 1993; 267: 496-505
20. Bing G, Filer D, Miller JC, Stone EA. Noradrenergic activation of immediate early genes in rat cerebral cortex. Mol Brain Res 1991; 11: 43-46.
21. Blanar MA, Rutter WJ. Interaction cloning: identification of a helix-loop-helix zipper protein that interacts with c-Fos. Science 1992; 256: 1014-1018.
22. Boulden AM, Sealy LJ. Maximal serum stimulation of the c-fos serum response element requires both the serum response factor and a novel binding factor, SRE-Binding Protein. Mol Cell Biol 1992; 12: 4769-4783.
23. Bourtchuladze R, Frenguelli B, Blendy J, Cioffi D, Schutz G, Silva AJ. Deficient long-term memory in mice with a targeted mutation of the cAMP-responsive element-binding protein. Cell 1994; 79: 59-68.
24. Brady LS, Lynn AB, Herkenham M, Gottesfeld Z. Systemic interleukin-1 induces early and late patterns of c-fos mRNA expression in brain. J Neurosci 1994; 14: 4951-4964.
25. Campeau S, Hayward MD, Hope BT, Rosen JB, Nestler EJ, Davis M. Induction of the c-fos proto-oncogene in rat amygdala during unconditioned and conditioned fear. Brain Res 1991; 565: 349-352.
26. Carney J.M., Tolliver B., Carney J.P., and Kindy M.S. Selective effects of behaviorally active doses of methamphetamine on mRNA expression in the gerbil brain. Neuropharmacology, 1991; 30: 1011-1019.
27. Carter DA. Neurotransmitter-stimulated immediate-early gene responses are organized through differential post-synaptic receptor mechanisms. Mol Brain Res 1992; 16: 111-118.
28. Cenci MA, Campbell K, Wictorin K, Björklund A. Striatal c-fos induction by cocaine or apomorphine occurs preferentially in output neurons projecting to the substantia nigra. Eur J Neurosci 1992; 4: 376-380.
29. Cenci MA, Björklund A. Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behavior in unilaterally 6-hydroxydopamine-lesioned rats. Eur J Neurosci 1993; 5: 1062-1070.
30. Cenci MA, Björklund A. Transection of corticostriatal afferents abolishes the hyperexpression of Fos and counteracts the development of rotational overcompensation induced by intrastriatal dopamine-rich grafts when challenged with amphetamine. Brain Res 1994; 665: 167-174.
31. Chang SL, Squinto SP, Harlan R. Morphine activation of c-fos expression in rat brain. Biochem Biophys Res Comm 1988; 157: 698-704.
32. 1 transition in cultured cells. EMBO J 1988; 7: 29-35.
33. Chavrier P, Janssen-Timmen U, Mattei MG, Zerial M, Bravo R, Charnay P. Structure, chromosome location, and expression of the mouse zinc finger gene Krox-20: multiple gene products and coregulation with the proto-oncogene c-fos. Mol Cell Biol 1989; 9: 787-797.
34. Chen CYA, You Y, Shyu AB. Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability. Mol Cell Biol 1992; 12: 5748-5757.
35. Chen RH, Abate C, Blenis J. Phosphorylation of the c-Fos transrepression domain by mitogen-activated protein kinase and 90-kDa ribosomal S6 kinase. Proc Natl Acad Sci USA 1993; 90: 10952-10956.
36. Chiasson BJ, Hooper ML, Murphy PR, Robertson HA. Antisense oligonucleotide eliminates in vivo espression of c-fos in mammalian brain. Eur J Pharmacol 1992; 227: 451-453.
37. Chiasson BJ, Dennison Z, Robertson HA. Amygdala kindling and immediate-early genes. Mol Brain Res 1995; 29: 191-199.
38. Chieng B, Keay KA, Christie MJ. Increased Fos-like immunoreactivity in the periaqueductal gray of anaesthetized rats during opiate withdrawal. Neurosci Lett 1995; 183: 79-82.
39. Chiu R, Angel P, Karin M. Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun. Cell 1989; 59: 979-986.
40. Christy BA, Lau LF, Nathans D. A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc Natl Acad Sci USA 1988; 85: 7857-7861.
41. Clegg DA, O'Hara BF, Heller HC, Kilduff TS. Nicotine administration differentially affects gene expression in the maternal and fetal circadian clock. Dev Brain Res 1995; 84: 46-54.
42. Clow DW, Hammer RP Jr. Cocaine abstinence following chronic treatment alters cerebral metabolism in dopaminergic reward regions - bromocriptine enhances recovery. Neuropsychopharmacology 1991; 4: 71-75.
43. Cohen DR, Curran T. fra-1: serum-inducible, cellular immediate-early gene that encodes a Fos-related antigen. Mol Cell Biol 1988; 8: 2063-2069.
44. Cohen DR, Ferreira PCP, Gentz R, Franza BR Jr, Curran T. The product of a fos-related gene, fra-1, binds cooperatively to the AP-1 site with Jun: transcription factor AP-1 is comprised of multiple protein complexes. Genes Dev 1989; 3: 173-184.
45. Cole AJ, Abu-Shakra S, Saffen DW, Baraban JM, Worley PF. Rapid rise in transcription factor mRNAs in rat brain after electroshock-induced seizures. J Neurochem 1990; 55: 1920-1927.
46. 1 dopamine receptor activation of multiple transcription factor genes in rat striatum. J Neurochem 1992; 58: 1420-1426.
47. Cole RL, Konradi C, Douglass J, Hyman SE. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 1995; 14: 813-823.
48. Costantini LC, Vozza BM, Snyder-Keller AM. Enhanced efficacy of nigral-striatal cotransplants in bilaterally dopamine-depleted rats: an anatomical and behavioral analysis. Exp Neurol 1994; 127: 219-231.
49. Couceyro P, Pollock KM, Drews K, Douglass J. Cocaine differentially regulates Activator Protein-1 mRNA levels and DNA-binding complexes in the rat striatum and cerebellum. Mol Pharmacol 1994; 46: 667-676.
50. Couceyro P, Douglass J. Precipitated morphine withdrawal stimulates multiple Activator Protein-1 signaling pathways in rat brain. Mol Pharmacol 1995; 47: 29-39.
51. Craviso GL, Hemelt VB, Waymire JC. The transient nicotinic stimulation of tyrosine hydroxylase gene transcription in bovine adrenal chromaffin cells is independent of c-fos gene activation. Mol Brain Res 1995; 29: 233-244.
52. Crook ST. Therapeutic applications of oligonucleotides. Ann Rev Pharmacol Toxicol 1992; 32: 329-376.
53. Dai G, Levy O, Carrasco N. Cloning and characterization of the thyroid iodide transporter. Nature 1996; 379: 458-460.
54. Dash PK, Hochner B, Kandel ER. Injection of the cAMP-responsive element into the nucleus of Aplysia sensory neurons blocks long-term facilitation. Nature 1990; 345: 718-721.
55. 2+/calmodulin- as well as cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1991; 88: 5061-5065.
56. Daunais JB, Roberts DCS, McGinty JF. Cocaine self-administration increases preprodynorphin, but not c-fos mRNA in rat striatum. NeuroReport 1993; 4: 543-546.
57. Daunais JB, McGinty JF. Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 1994; 18: 35-45.
58. Daunais JB, McGinty JF. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Mol Brain Res 1995; 29: 201-210.
59. Davis IJ, Lau LF. Endocrine and neurogenic regulation of the orphan nuclear receptors Nur77 and Nurr-1 in the adrenal glands. Mol Cell Biol 1994; 14: 3469-3483.
60. De Felipe C, Hunt SP. The differential control of c-jun expression in regenerating sensory neurons and their associated glial cells. J Neurosci 1994; 14: 2911-2923.
61. Deutch AY, Roth RH. The determinants of stress-induced activation of the prefrontal cortical dopamine system. Prog Brain Res 1990; 85: 357-393.
62. Deutch AY, Lee MC, Gillham MH, Cameron DA, Goldstein M, Iadarola MJ. Stress selectively increases Fos protein in dopamine neurons innervating the prefrontal cortex. Cerebral Cortex 1991; 1: 273-292.
63. Dey A, Nebert DW, Ozato K. The AP-1 site and the cAMP- and serum response elements of the c-fos gene are constitutively occupied in vivo. DNA Cell Biol 1991; 10: 537-544.
64. Diamond ME, Huang W, Ebner FF. Laminar comparison of somatosensory cortical plasticity. Science 1994; 265: 1885-1888.
65. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR. Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 1990; 249: 1266-1272.
66. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-5278.
67. Di Chiara G, North RA. Neurobiology of opiate use. Trends Pharmacol Sci 1992; 13: 185-193.
68. Dilts RP Jr, Helton TE, McGinty JF. Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields. Synapse 1993; 13: 251-263.
69. Dinan TG. Glucocorticoids and the genesis of depressive illness - a psychobiological model. Br J Psychiatry 1994; 164: 365-371.
70. Dragunow M, Robertson HA. Kindling stimulation induces c-fos protein(s) in granule cells of the rat dentate gyrus. Nature 1987; 329: 441-442.
71. Dragunow M, Robertson HA. Brain injury induces c-fos protein(s) in nerve and glial-like cells in adult mammalian brain. Brain Res 1988; 455: 295-299.
72. Dragunow M, Lawlor P, Chiasson B, Robertson HA. C-fos antisense generates apomorphine and amphetamine-induced rotation. NeuroReport 1993; 5: 305-306.
73. Draisci G, Iadarola M. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol Brain Res 1989; 6: 31-37.
74. Dworkin SI, Smith JE. Cortical regulation of self-administration. Ann NY Acad Sci 1992; 654: 274-281.
75. Ebert U, Loscher W. Strong induction of c-fos in the piriform cortex during focal seizures evoked from different limbic brain sites. Brain Res 1995; 671: 338-344.
76. Ennulat DJ, Babb SM, Cohen BM. Persistent reduction of immediate early gene mRNA in rat forebrain following single or multiple doses of cocaine. Mol Brain Res 1994; 26: 106-112.
77. Evans RM, Hollenberg SM. Zinc fingers: gilt by association. Cell 1988; 52: 1-3.
78. Flanagan-Cato LM, McEwen BS. Pattern of Fos and Jun expression in the female rat forebrain after sexual behavior. Brain Res 1995; 673: 53-60.
79. Flemmer DD, Dilsaver SC. Chronic injections of saline produce subsensitivity to nicotine. Pharmacol Biochem Behav 1989; 34: 261-263.
80. Foulkes NS, Borrelli E, Sassone-Corsi P. CREM gene: use of alternative DNA-binding domains generates multiple antagonists of cAMP-induced transcription. Cell 1991; 64: 739-749.
81. Franklin CC, Snachez V, Wagner F, Woodgett JR, Kraft AS. Phorbol ester-induced amino-terminal phosphorylation of human Jun but not JunB regulates transcriptional activation. Proc Natl Acad Sci USA 1992; 89: 7247-7251.
82. Fung BP, Yoon SO, Chikaraishi DM. Sequences that direct rat tyrosine hydroxylase gene expression. J Neurochem 1992; 58: 2044-2052.
83. Fuxe K, Agnati LF, Rosen L, Bjelke B, Cintra A, Bortolotti F, Tinner B, Andersson C, Hasselroth U, Steinbusch H, Gustafsson JA, Benfenati F. Computer-assisted image analysis techniques allow a characterization of the compartments within the basal ganglia. Focus on functional compartments produced by d-amphetamine activation of the c-fos gene and its relationship to the glucocorticoid receptor. J Chem Neuroanat 1991; 4: 355-372.
84. Gass P, Herdegen T, Bravo R, Kiessling M. Induction of immediate early gene encoded proteins in the rat hippocampus after bicuculline-induced seizures: differential expression of Krox-24, Fos and Jun proteins. Neuroscience 1992; 48: 315-324.
85. Gawin FH. Cocaine addiction: psychology and neurophysiology. Science 1991; 251: 1580-1586.
86. Gawin FH, Kleber HD. Abstinence symptomatology and psychiatric diagnosis in cocaine abusers: clinical observations. Arch Gen Psychiatry 1986; 43: 107-113.
87. Gille H, Sharrocks AD, Shaw PE. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature 1992; 358: 414-417.
88. Goc A, Stachowiak MK. Bovine tyrosine hydroxylase gene-promoter regions involved in basal and angiotensin II-stimulated expression in nontransformed adrenal medullary cells. J Neurochem 1994: 62: 834-843.
89. Gonzalez GA, Yamamoto KK, Fischer WH, Karrs D, Manzel P, Biggs W III, Vale WW, Montminy MR. A cluster of phosphorylation sites on the cyclic AMP-regulated nuclear factor CREB predicted by its sequence. Nature 1989; 337: 749-752.
90. Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 1989; 59: 675-680.
91. Gonzalez-Martin C, de Diego I, Crespo D, Fairen A. Transient c-fos expression accompanies naturally occurring cell death in the developing interhemispheric cortex of the rat. Dev Brain Res 1992; 68: 83-95.
92. Graham R, Gilman M. Distinct protein targets for signals acting at the c-fos serum response element. Science 1991; 251: 189-192.
93. Grassi-Zucconi G, Menegazzi M, Carcerari de Prati A, Bassetti A, Montagnese P, Mandile P, Cosi C, Bentivoglio M. c-fos mRNA is spontaneously induced in the rat brain during the activity period of the circadian cycle. Eur J Neurosci 1993; 5: 1071-1078.
94. Graybiel AM, Moratalla R, Robertson HA. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc Natl Acad Sci USA 1990; 87: 6912-6916.
95. Gubits RM, Smith TM, Fairhurst JL, Yu H. Adrenergic receptors mediate changes in c-fos mRNA levels in brain. Mol Brain Res 1989; 6: 39-45.
96. Guitart X, Thompson MA, Mirante CK, Greenberg ME, Nestler EJ. Regulation of CREB phosphorylation by acute and chronic morphine in the rat locus coeruleus. J Neurochem 1992; 58: 1168-1171.
97. Guthrie KM, Anderson AJ, Leon M, Gall C. Odor-induced increases in c-fos mRNA expression reveal an anatomical "unit" for odor processing in olfactory bulb. Proc Natl Acad Sci USA 1993; 90: 3329-3333.
98. Haby C, Lisovoski F, Aunis D, Zwiller J. Stimulation of the cyclic GMP pathway by NO induces expression of the immediate early genes c-fos and jun-B in PC12 cells. J Neurochem 1994; 62: 496-501.
99. Hai T, Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 1991; 88: 3720-3724.
100. Hamamura M, Nunez DJR, Leng G, Emson PC, Kiyama H. c-fos may code for a common transcription factor within the hypothalamic neural circuits involved in osmoregulation. Brain Res 1992; 572: 42-51.
101. Hammer RP Jr, Pires WS, Markou A, Koob GF. Withdrawal following cocaine self-administration decreases regional cerebral metabolic rate in critical brain reward regions. Synapse 1993; 14: 73-80.
102. Hanley MR. Proto-oncogenes in the nervous system. Neuron 1988; 1: 175-182.
103. Hayes TE, Kitchen AM, Cochran BH. Inducible binding of a factor to the c-fos regulatory region. Proc Natl Acad Sci USA 1987; 84: 1272-1276.
104. Hayward MD, Duman RS, Nestler EJ. Induction of the c-fos proto-oncogene during opiate withdrawal in the locus coeruleus and other regions of the rat brain. Brain Res 1990; 525: 256-266.
105. He X, Rosenfeld MG. Mechanisms of complex transcriptional regulation: implications for brain development. Neuron 1991; 7: 183-196.
106. Heilig M, Engel JA, Soderpalm B. C-fos antisense in the nucleus accumbens blocks the locomotor stimulant action of cocaine. Eur J Pharmacol 1993; 236: 339-340.
107. Heilig M, Schlingensiepen KH. Antisense oligonucleotides as novel pharmacological tools for selective expression blockade in the brain. In: Latchman DS, ed, Genetic Manipulation of the Nervous System. London: Academic Press, 1996: 249-268.
108. Hengerer B, Lindholm D, Heumann R, Ruther U, Wagner EF, Thoenen H. Lesion-induced increase in nerve growth factor mRNA is mediated by c-fos. Proc Natl Acad Sci USA 1990; 87: 3899-3903.
109. Henriksen SJ, Giacchino J. Functional characteristics of nucleus accumbens neurons: evidence obtained from in vivo electrophysiological recordings. In: Kalivas PW, Barners CD, eds, Limbic Motor Circuits and Neuropsychiatry. Boca Raton, FL: CRC Press, 1993; 101-124.
110. Herdegen T, Tolle TR, Bravo R, Zieglgansberger W, Zimmermann M. Sequential expression of JUN B, JUN D and FOS B proteins in rat spinal neurons: cascade of transcriptional operations during nociception. Neurosci Lett 1991; 129: 221-224.
111. Herdegen T, Kiessling M, Bele S, Bravo R, Zimmermann M, Gass P. The Krox-20 transcription factor in the rat central and peripheral nervous systems: novel expression pattern of an immediate early gene-encoded protein. Neuroscience 1993; 57: 41-52.
112. Herr W, Strum RA, Clerc RG, Corcoran LM, Baltimore D, Sharp PA, Ingraham HA, Rosenfeld MG, Finney M, Ruvkun G, Horvitz HR. The POU domain: a large conserved region in the mammalian Pit-1, Oct-1, Oct-2 and Caenorhabditis elegans unc-86 gene products. Genes Dev 1991; 2: 1513-1521.
113. Herrera DG, Robertson HA. Unilateral induction of c-fos protein in cortex following cortical devascularization. Brain Res 1989; 503: 205-213.
114. Herschman HR. Primary response genes induced by growth factors and tumor promoters. Ann Rev Biochem 1991; 60: 281-319.
115. Hirai SI, Ryseck RP, Mechta F, Bravo R, Yaniv M. Characterization of junD: a new member of the jun proto-oncogene family. EMBO J 1989; 8: 1433-1439.
116. Hisanaga K, Sagar SM, Sharp FR. N-Methyl-D-aspartate antagonists block Fos-like protein expression induced via multiple signaling pathways in cultured cortical neurones. J Neurochem 1992; 58: 1836-1844.
117. Honkaniemi J, Sagar SM, Pyykonen I, Hicks K, Sharp FR. Focal brain injury induces multiple immediate early genes encoding zinc finger transcription factors. Mol Brain Res 1995; 28: 157-163.
118. Hooper ML, Chiasson BJ, Robertson HA. Infusion into the brain of an antisense oligonucleotide to the immediate-early gene c-fos suppresses production of Fos and produces a behavioral effect. Neuroscience 1994; 63: 917-924.
119. Hope B, Kosofsky B, Hyman SE, Nestler EJ. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci USA 1992; 89: 5764-5768.
120. Hope BT, Nye HE, Kelz MB, Self DW, Iadarola MJ, Nakabeppu Y, Duman RS, Nestler EJ. Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments. Neuron 1994; 13: 1235-1244.
121. Hope BT, Kelz MB, Duman RS, Nestler EJ. Chronic electroconvulsive seizure (ECS) treatment results in expression of a long-lasting AP-1 complex in brain with altered composition and characteristics. J Neurosci 1994; 14: 4318-4328.
122. Huang YY, Li X, Kandel ER. cAMP contributes to mossy fiber LTP by initiating both a covalently mediated early phase and macromolecular synthesis-dependent late phase. Cell 1994; 79: 69-79.
123. Hunt SP, Pini A, Evan G. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987; 328: 632-634.
124. Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell 1992; 70: 375-387.
125. Hurst HC, Masson N, Jones NC, Lee KAW. The cellular transcription factor CREB corresponds to Activating Transcription Factor 47 (ATF-47) and forms complexes with a group of polypeptides related to ATF-43. Mol Cell Biol 1990; 10: 6192-6203.
126. Iadarola MJ, Chuang EJ, Yeung CL, Hoo Y, Silverthorn M, Gu J, Draisci G. Induction and suppression of proto-oncogenes in rat striatum after single or multiple treatments with cocaine or GBR-12909. NIDA Res Monograph 1993; 125: 181-211.
127. Jackson RJ. Cytoplasmic regulation of mRNA function: the importance of the 3′ untranslated region. Cell 1993: 74: 9-14.
128. Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T, Rao A. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature 1993; 365: 352-356.
129. Jenkins R, Hunt SP. Long-term increases in the levels of c-jun mRNA and Jun protein-like immunoreactivity in motor and sensory neurons following axon damage. Neurosci Lett 1991; 129: 107-110.
130. Jhaveri S, Erzurumlu RS, Crossin K. Barrel construction in rodent neocortex: role of thalamic afferents versus extracellular matrix molecules. Proc Natl Acad Sci USA 1991; 88: 4489-4493.
131. Johanson B, Lindstrom K, Fredholm BB. Differences in the regional and cellular localization of c-fos messenger RNA induced by amphetamine, cocaine and caffeine in the rat. Neuroscience 1994; 59: 837-49.
132. Johnson RS, Spiegelman BM, Papaioannou V. Pleiotropic effects of a null mutation in the c-fos proto-oncogene. Cell 1992; 71: 577-586.
133. Joseph LJ, Le Beau MM, Jamieson GA Jr, Acharya S, Shows TB, Rowley JD, Sukhatme VP. Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. Proc Natl Acad Sci USA 1988; 85: 7164-7168.
134. Kadonaga JT, Carner KR, Masiarz FR, Tjian R. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 1987; 51: 1079-1090.
135. Kandel ER, Jessell T. Early experience and the fine tuning of synaptic connections. In: Kandel ER, Schwartz JH, Jessell TM, eds, Principles of Neuroscience. Norwalk: Appleton & Lange, 1991; 945-958.
136. Karin M. Signal transduction from cell surface to nucleus in development and disease. FASEB J 1992; 6: 2581-2590.
137. Kerppola TK, Curran T. DNA bending by Fos and Jun: the flexible hinge model. Science 1991; 254: 1210-1214.
138. Kiba H, Jayaraman A. Nicotine induced c-fos expression in the striatum is mediated mostly by dopamine D1 receptor and is dependent on NMDA stimulation. Mol Brain Res 1994; 23: 1-13.
139. Kim KS, Lee MK, Carroll J, Joh TH. Both basal and inducible transcription of the tyrosine hydroxylase gene are dependent upon a cAMP response element. J Biol Chem 1993; 268: 15689-15695.
140. Kim KS, Ishiguro H, Tinti C, Wagner J, Joh TH. The cAMP-dependent protein kinase regulates transcription of the dopamine β-hydroxylase gene. J Neurosci 1994; 14: 7200-7207.
141. Kimes AS, London ES. Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal. J Pharmacol Exp Ther 1989; 248: 538-545.
142. Klitenick MA, Tham CS, Fibiger HC. Cocaine and d-amphetamine increase c-fos expression in the rat cerebellum. Synapse 1995; 19: 29-36.
143. Kobierski LA, Chu HM, Tan Y, Comb MJ. cAMP-dependent regulation of proenkephalin by JunD and JunB: positive and negative effects of AP-1 proteins. Proc Natl Acad Sci USA 1991; 88: 10222-10226.
144. Koistinaho J, Pelto-Huikko M, Sagar SM, Dagerlind A, Roivainen R, Hokfelt T. Differential expression of immediate early genes in the superior cervical ganglion after nicotine treatment. Neurosci 1993; 56: 729-739.
145. Kokkinidis L. Neurochemical correlates of post-amphetamine depression and sensitization in animals. In: Simon P, Soubrie P, Widlocher D, eds, Animal Models of Psychiatric Disorders, Vol 2. Basel: Karger, 1988; 148-173.
146. Kokkinidis L, Zacharko RM, Predy PA. Post-amphetamine depression of self-stimulation responding from the substantia nigra: reversal by tricyclic antidepressants. Pharmacol Biochem Behav 1980; 13: 379-383.
147. Konradi C, Kobierski LA, Nguyen TV, Heckers S, Hyman SE. The cAMP-response-element-binding protein interacts, but Fos protein does not interact, with the proenkephalin enhancer in rat striatum. Proc Natl Acad Sci USA 1993; 90: 7005-7009.
148. Konradi C, Cole RL, Heckers S. Hyman SE. Amphetamine regulated gene expression in rat striatum via transcription factor CREB. J Neurosci 1994; 14: 5623-5634.
149. Koob GF. Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 1992; 13: 177-184.
150. Kernhauser JM, Nelson DE, Mayo KE, Takahashi JS. Photic and circadian regulation of c-fos gene expression in the hamster suprachiasmatic nucleus. Neuron 1990; 5: 127-134.
151. Kosofsky BE, Genova LM, Hyman SE. Postnatal age defines specificity of immediate early gene induction by cocaine in developing rat brain. J Comp Neurol 1995; 351: 27-40.
152. Kosofsky BE, Genova LM, Hyman SE. Substance P phenotype defines specificity of c-Fos induction by cocaine in developing rat striatum. J Comp Neurol 1995; 351: 41-50.
153. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol 1987; 196: 947-950.
154. Kramer JC, Fischman VS, Littlefield DC. Amphetamine abuse - patterns and effects of high doses taken intravenously. JAMA 1967; 201: 305-309.
155. Kumar V, Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 1988; 55: 145-156.
156. Labiner DM, Butler LS, Cao Z, Hosford DA, Shin C, McNamara JO. Induction of c-fos mRNA by kindled seizures: complex relationship with neuronal burst firing. J Neurosci 1993; 13: 744-751.
157. Lahiri DK, Nall C. Two AP-1 sites are necessary for the promoter activity of APP gene in astrocyte cells. Soc Neurosci Abstr 1992; 18: 1464.
158. 2 synergism and receptor supersensitivity. Proc Natl Acad Sci USA 1993; 90: 7451-7455.
159. Lamb NJ, Fernandez A, Tourkine N, Jeanteur P, Blanchard JM. Demonstration in living cells of an intragenic negative regulatory element within the rodent c-fos gene. Cell 1990; 61: 485-496.
160. Lambert PD, Phillips PJ, Wilding JPH, Bloom SR, Herbert J. c-fos expression in the paraventricular nucleus of the hypothalamus following intracerebroventricular infusions of neuropeptide Y. Brain Res 1995; 670: 59-65.
161. Lanahan A, Williams JB, Sanders LK, Nathans D. Growth factor-induced delayed early response genes. Mol Cell Biol 1992; 12: 3919-3929.
162. Le F, Wilce P, Cassidy AI Hume DA, Shanley BC. Acute administration of ethanol suppresses pentylentetrazole-induced c-fos expression in rat brain. Neurosci Lett 1990; 120: 271-274.
163. Leith NJ, Barrett RJ. Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychopharmacology 1976; 46: 19-25.
164. Lemaire P, Revelant O, Bravo R, Charnay P. Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 1988; 85: 4691-4695.
165. Li X, Song L, Kolasa K, Jope RS. Adrenalectomy potentiates immediate early gene expression in rat brain. J Neurochem 1992; 58: 2330-2333.
166. Liu J, Nickolenko J, Sharp FR. Morphine induces c-fos and junB in striatum and nucleus accumbens via D1 and N-methyl-D-aspartate receptors. Proc Natl Acad Sci USA 1994; 91: 8537-8541.
167. Loriaux MM, Rehfuss RP, Brennan RG, Goodman RH. Engineered leucine zippers show that hemiphosphorylated CREB complexes are transcriptionally active. Proc Natl Acad Sci USA 1993; 90: 9046-9050.
168. Luckman SM, Dyball EJ, Leng G. Induction of c-fos expression in hypothalamic magnocellular neurons requires synaptic activation and not simply increased spike activity. J Neurosci 1994; 14: 4825-4830.
169. Lucibello FC, Slater EP, Jooss KU, Beato M, Muller R. Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J 1990; 9: 2827-2834.
170. McCabe BJ, Horn G. Learning-related changes in Fos-like immunoreactivity in the chick forebrain after imprinting. Proc Natl Acad Sci USA 1994; 91: 11417-11421.
171. McCasland JS, Bernardo KL, Probst KL, Woolsey TA. Cortical local circuit axons do not mature after early deafferentation. Proc Natl Acad Sci USA 1992; 89: 1832-1836.
172. Mack KJ, Yi SD, Chang S, Millan N, Mack P. NGFI-C expression is affected by physiological stimulation and seizures in the somatosensory cortex. Mol Brain Res 1995; 29: 140-146.
173. Mackler SA, Eberwine JH. Cellular adaptation to opiates alters ion-channel mRNA levels. Proc Natl Acad Sci USA 1994; 91: 385-389.
174. Mailleux P, Verslype M, Preud'homme X, Vanderhaeghen JJ. Activation of multiple transcription factor genes by tetrahydrocannabinol in rat forebrain. NeuroReport 1994; 5: 1265-1268.
175. Mandel G, McKinnon D. Molecular basis of neural-specific gene expression. Ann Rev Neurosci 1993; 16: 323-345.
176. Marais R, Wynne J, Treisman R. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 1993; 73: 381-393.
177. Marota JJA, Crosby G, Uhl GR. Selective effects of pentobarbital and halothane on c-fos and jun-B gene expression in rat brain. Anesthesiology 1992; 77: 365-371.
178. Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attar-Levy D, Pappata S, Syrota A. Left prefrontal glucose hypometabolism in the depressed
179. Matsumoto I, Davidson M, Wilce PA. Polyamine-enhanced NMDA receptor activity: effect of ethanol. Eur J Pharmacol, 1993; 247: 289-294.
180. Matta SG, Foster CA, Sharp BM. Nicotine stimulates the expression of c-Fos protein in the parvocellular paraventricular nucleus and brainstem catecholaminergic regions. Endocrinology 1993; 132: 2149-2156.
181. Melia KR. Ryabinin AE, Schroeder R, Bloom FE, Wilson MC. Induction and habituation of immediate early gene expression in rat brain by acute and repeated restraint stress. J Neurosci 1994; 14: 5929-5938.
182. Merchant KM, Hanson GR, Dorsa DM. Induction of neurotensin and c-fos mRNA in distinct subregions of rat neostriatum after acute methamphetamine: comparison with acute haloperidol effects. J Pharmacol Exp Ther 1994; 269: 806-812.
183. Merchant KL, Miller MA. Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol. Mol Brain Res 1994; 23: 271-277.
184. Messersmith DJ, Gu J, Dubner R, Douglas J, Iadarola MJ. Basal and inducible transcriptional activity of an upstream AP-1/CRE element (DYNCRE3) in the prodynorphin promoter. Mol Cell Neurosci 1994; 5: 238-245.
185. Meyer DJ, Stephenson EW, Johnson L, Cochran BH, Schwartz J. The serum response element can mediate induction of c-fos by growth hormone. Proc Natl Acad Sci USA 1993; 90: 6721-6725.
186. Milbrandt J. A Nerve Growth Factor-induced gene encodes a possible transcriptional regulatory factor. Science 1987; 238: 797-799.
187. Miller JC. Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J Neurochem 1990; 54: 1453-1455.
188. Mitchell PJ, Tjian R. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 1989; 245: 371-378.
189. Mocchetti I, De Bernardi MA, Szekely AM, Alho H, Brooker G, Costa E. Regulation of nerve growth factor biosynthesis by β-adrenergic receptor activation in astrocytoma cells: a potential role of c-Fos protein. Proc Natl Acad Sci USA 1989; 86: 3891-3895.
190. Moller C, Bing O, Heilig M. C-fos expression in the amygdala: in vivo antisense modulation and role in anxiety. Cell Mol Neurobiol 1994; 14: 415-423.
191. Montminy MR, Gonzalez GA, Yamamoto KK. Regulation of cAMP-inducible genes by CREB. Trends Neurosci 1990; 13: 184-188.
192. Moratalla R, Robertson HA, Graybiel AM. Dynamic regulation of NGFI-A. (zif268, egr1) gene expression in the striatum. J Neurosci 1992; 12: 2609-2622.
193. Moratalla R, Vickers EA, Robertson HA, Cochran HB, Graybiel AM. Coordinate expression of c-fos and jun B is induced in the rat striatum by cocaine. J Neurosci 1993; 13: 423-433.
194. Morgan JI. Cohen DR, Hempstead JL, Curran T. Mapping patterns of c-fos expression in the central nervous system after seizure. Science 1987; 237: 192-197.
195. Morgan JI, Curran T. Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Ann Rev Neurosci 1991; 14: 421-451.
196. Murphy TH, Worley PF, Baraban JM. L-type voltage-sensitive calcium channels mediate synaptic activation of immediate early genes. Neuron 1991; 7: 625-635.
197. Nakabeppu Y, Nathans D. A naturally occurring truncated form of FosB that inhibits Fos/Jun transcriptional activity. Cell 1991; 64: 751-759.
198. Naranjo JR, Mellstrom B, Achaval M, Sassone-Corsi P. Molecular pathways of pain: Fos/Jun-mcdiated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron 1991; 6: 607-617.
199. Nardelli J, Gibson TJ, Vesque C, Charnay P. Base sequence discrimination by zinc-finger DNA-binding domains. Nature 1991; 349: 175-178.
200. Neckers L, Whitesell L, Rosolen A, Geselowitz DA. Antisense inhibition of oncogene expression. Crit Rev Oncogen 1992; 3: 175-231
201. Nedivi E, Hevroni D, Naot D, Israeli D, Citri Y. Numerous candidate plasticity-related genes revealed by differential cDNA cloning. Nature 1993; 363: 718-722.
202. Nestler EJ. Molecular mechanisms of drug addiction. J Neurosci 1992; 12: 2439-2450.
203. Ng L, Forrest D, Curran T. Differential roles for Fos and Jun in DNA-binding: redox-dependent and independent functions. Nucl Acid Res 1993; 21: 5831-5837.
204. Nguyen TV, Kosofsky BE, Birnbaum R, Cohen BM, Hyman SE. Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine and amphetamine. Proc Natl Acad Sci USA 1992; 89: 4270-4274.
205. Nichols M, Weih F, Schmid W, DeVack C, Kowenz-Leutz E, Luckow B, Boshart M, Schutz G. Phosphorylation of CREB affects its binding to high and low affinity sites: implications for cAMP induced gene transcription. EMBO J 1992; 11: 3337-3346.
206. Nishina H, Sato H, Suzuki T, Sato M, Iba H. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci USA 1990; 87: 3619-3623.
207. Norman AB, Lu SY, Klug JM, Norgren RB. Sensitization of c-fos expression in rat striatum following multiple challenges with D-amphetamine. Brain Res 1993; 603: 125-128.
208. Norman C, Runswick M, Pollock R, Treisman R. Isolation and properties of cDNA clones encoding SRF, a transcription factor the binds the c-fos serum response element. Cell 1988; 55: 989-1003.
209. Ofir R, Dwarki VJ, Rashid D, Verma IM. Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter. Nature 1990; 348: 80-82.
210. O'Hara BF, Young KA, Watson FL, Heller HC, Kilduff TS. Immediate early gene expression in brain during sleep deprivation: preliminary observations. Sleep 1993; 16: 1-7.
211. Pabo CO, Sauer RT. Transcription factors: structural families and principles of DNA recognition. Ann Rev Biochem 1992; 61: 1053-1095.
212. Pang Y, Kiba H, Jayaraman A. Acute nicotine injections induce c-fos mostly in non-dopaminergic neurons of the midbrain of the rat. Mol Brain Res 1993; 20: 162-170.
213. Patel LR, Curran T, Kerppola TK. Energy transfer analysis of Fos-Jun dimerization and DNA binding. Proc Natl Acad Sci USA 1994; 91: 7360-7364.
214. Pennypacker KR, Thai L, Hong JS, McMillian MK. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J Neurosci 1994; 14: 3998-4006.
215. Persico AM, Schindler CW, Brannock MT, Gonzalez AM, Surratt CK, Uhl GR. Dopaminergic gene expression during amphetamine withdrawal. NeuroReport 1993; 4: 41-44.
216. Persico AM, Schindler CW, O'Hara BF, Brannock MT, Uhl GR. Brain transcription factor expression: effects of acute and chronic amphetamine and injection stress. Mol Brain Res 1993; 20: 91-100.
217. Persico AM, Schindler CW, Davis S, Ambrosio E, Uhl GR. Amphetamine withdrawal-related behaviors induced by medial prefrontal cortical injections of c-fos antisense oligonucleotides in the rat. Soc Neurosci Abst 1994; 20: 1620.
218. Persico AM, Schindler CW, Zaczek R, Brannock MT, Uhl GR. Brain transcription factor gene expression, neurotransmitter levels, and novelty response behaviors: alterations during rat amphetamine withdrawal and following chronic injection stress. Synapse 1995; 19: 212-227.
219. Piazza PV, Rouge-Pont F, Deminiere PV, Kharoubi M, le Moal M, Simon S. Dopaminergic activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration. Brain Res 1991; 567: 169-174.
220. Piech KM, Best JA, Tank AW. Protein interactions with a putative AP1 element in the rat tyrosine hydroxylase gene promoter. Soc Neurosci Abstr 1992; 18: 244.
221. Ptashne M, Gann AAF. Activators and targets. Nature 1990; 346: 329-331.
222. Quinn P. Distinct activation domains within cAMP Response Element-Binding Protein (CREB) mediate basal and cAMP-stimulated transcription. J Biol Chem 1993; 268: 16999-17009.
223. Rimondini R, Sommer W, O'Connor WT, Hansson A, Fuxe K, Ungerstedt U. Intrastriatal c-fos antisense oligonucleotide decreases GABA release in the substantia nigra but not in the globus pallidus. An in vivo microdyalisis study in the awake rat. Soc Neurosci Abs 1995; 21: 1375.
224. 3H]dopamine release from rat striatum: an in vitro model of glutamate actions. J Neurochem 1979; 32: 1539-1545.
225. Robertson GS, Vincent SR, Fibiger HC. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res 1990; 523: 288-290.
226. Robertson GS, Fibiger HC. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of halopericdol and clozapine. Neuroscience 1992; 46: 315-328.
227. 1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour. Brain Res 1989; 503: 346-349.
228. Robertson HA, Paul ML, Moratalla R. Graybiel AM. Expression of the immediate early gene c-fos in basal ganglia: induction by dopaminergic drugs. Can J Neurol Sci 1991; 18: 380-383.
229. Robertson LM, Kerppola TK, Vendrell M, Luk D, Smeyne RJ, Bocchiaro C, Morgan JI, Curran T. Regulation of c-fos expression in transgenic mice requires multiple interdependent transcription control elements. Neuron 1995; 14: 241-252.
230. Robinson TE, Becker JB. Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis. Brain Res Rev 1986; 11: 157-198.
231. Rogue P, Malviya AN. Neuroleptics differentially induce jun family genes in the rat striatum. NeuroReport 1994; 5: 501-503.
232. Rose SPR. How chicks make memory: the cellular cascade from c-fos to dendritic remodelling. Trends Neurosci 1991; 14: 390-397.
233. Rosen JB, Chuang E, Iadarola MJ. Differential induction of Fos protein and a Fos-related antigen following acute and repeated cocaine administration. Mol Brain Res 1994; 25: 168-172.
234. Rosen KM, McCormack MA, Villa-Komaroff L, Mower GD. Brief visual experience induces immediate early gene expression in the cat visual cortex. Proc Natl Acad Sci USA 1992; 89: 5437-5441.
235. Roux P, Blanchard JM, Fernandez A, Lamb N, Jeanteur P, Piechaczyk M. Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals. Cell 1990; 63: 341-351.
236. Rowland NE, Li BH, Fregly MJ, Smith GC. Fos induced in brain of spontaneously hypertensive rats by angiotensin II and co-localization with AT-1 receptors. Brain Res 1995; 675: 127-134.
237. Ruskin DN, Marshall JF. Amphetamine- and cocaine-induced Fos in the rat striatum depends on D2 dopamine receptor activation. Synapse 1994; 18: 233-240.
238. Ruvkun G, Finney M. Regulation of transcription and cell identity by POU domain proteins. Cell 1991; 64: 475-478.
239. Ryabinin AE, Melia KR, Cole M, Bloom FE, Wilson MC. Alcohol selectively attenuates stress-induced c-fos expression in rat hippocampus. J Neurosci 1995; 15: 721-730.
240. Ryder K, Lau LF, Nathans D. A gene activated by growth factors is related to the oncogene v-jun. Proc Natl Acad Sci USA 1988; 85: 1487-1491.
241. Ryder K, Nathans D. Induction of protooncogene c-jun by serum growth factors. Proc Natl Acad Sci USA 1988; 85: 8464-8467.
242. Ryder K, Lanahan A, Perez-Albuerne E, Nathans D. Jun-D: a third member of the Jun gene family. Proc Natl Acad Sci USA 1989; 86: 1500-1503.
243. Ryseck RP, Bravo R. c-Jun, Jun-B and Jun-D differ in their binding affinity to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene 1991; 6: 533-542.
244. Saffen DW, Cole AJ, Worley PF, Christy BA, Ryder K, Baraban JM. Convulsant-induced increase in transcription factor messenger RNAs in rat brain. Proc Natl Acad Sci USA 1988; 85: 7795-7799.
245. Sagar SM, Sharp FR, Curran T. Expression of c-fos protein in brain: a novel method of neuroanatomic metabolic mapping at the cellular level. Science 1988; 240: 1328-1331.
246. Sallaz M, Jourdan F. C-fos expression and 2-deoxyglucose uptake in the olfactory bulb of odour-stimulated awake rats. NeuroReport 1993; 4: 55-58.
247. Sassone-Corsi P, Sisson JC, Verma IM. Transcriptional autoregulation of the proto-oncogene fos. Nature 1988; 334: 314-319.
248. Schildkraut JJ, Watson R, Draskoczy PR, Hartmann E. Amphetamine withdrawal: depression and M.H.P.G. excretion. Lancet 1971; 2: 485-486.
249. Schindler CW, Persico AM, Uhl GR, Goldberg SR. Behavioral assessment of high-dose amphetamine withdrawal: importance of training and testing conditions. Pharmacol Biochem Behav 1994; 49: 41-46.
250. Schreiber H, Bell R, Conely L, Kufner M, Palet J, Wright L. Diminished reaction to a novel stimulus during amphetamine withdrawal in rats. Pharmacol Biochem Behav 1976; 5: 687-690.
251. Sharp FR, Gonzalez MF, Hisanaga K, Mobley WC, Sagar SM. Induction of the c-fos gene product in rat forebrain following cortical lesions and NGF injections. Neurosci Lett 1989; 100: 117-122.
252. Sharp FR, Griffith J, Gonzalez MF, Sagar SM. Trigeminal nerve section induces Fos-like immunoreactivity (FLI) in brainstem and decreases FLI in sensory cortex. Mol Brain Res 1989; 6: 217-220.
253. 14C]2-deoxyglucose uptake in the caudal cerebellum of the rat during motor/sensory cortex stimulation. J Comp Neurol 1989; 284: 621-636.
254. Sharp FR, Liu J, Nickolenko J, Bontempi B. NMDA and D1 receptors mediate induction of c-fos and jun-B genes in striatum following morphine administration: implications for studies of memory. Behav Brain Res 1995; 66: 225-230.
255. 2-adrenoceptor drugs. Mol Brain Res 1995; 28: 222-230.
256. Sheng M, Greenberg ME. The regulation and function of c-fos and other immediate early genes in the nervous system. Neuron 1990; 4: 477-485.
257. Sheng M, McFadden G, Greenberg M. Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 1990; 4: 571-582.
258. Shyu AB, Belasco JG, Greenberg ME. Two distinct destabilizing elements in the c-fos message trigger deadenylation as a first step in rapid mRNA decay. Genes Dev 1991; 5: 221-231.
259. Smeal T, Binetruy B, Mercola D, Grover-Bardwick A, Heidecker G, Rapp UR, Karin M. Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73. Mol Cell Biol 1992; 12: 3507-3513.
260. Snyder-Keller AM. Striatal c-fos induction by drugs and stress in neonatally dopamine-depleted rats given nigral transplants: importance of NMDA activation and relevance to sensitization phenomena. Exp Neurol 1991; 113: 155-165.
261. Sommer W, Bjelke B, Ganten D, Fuxe K. Antisense oligonucleotide to c-fos induced ipsilateral rotational behaviour to d-amphetamine. NeuroReport 1993; 5: 277-280.
262. Sonnenberg JL, Rauscher FJ III, Morgan JI, Curran T. Regulation of proenkephalin by proto-oncogenes fos and jun. Science 1989; 246: 1622-1625.
263. Sonnenberg JL, Macgregor-Leon PF, Curran T, Morgan JI. Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron 1989; 3: 359-365.
264. Stachowiak MK, Goc A, Hong JS, Poisner A, Jiang HK, Stachowiak EK. Regulation of tyrosine hydroxylase gene expression in depolarized nontransformed bovine adrenal medullary cells: second messenger systems and promoter mechanisms. Mol Brain Res 1994; 22: 309-319.
265. Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents - is the bullet really magical? Science 1993; 261: 1004-1012.
266. Stein EA, Fuller SA. Selective effects of cocaine on regional cerebral blood flow in the rat. J Pharmacol Exp Ther 1992; 262: 327-334.
267. Steiner H, Gerfen CR. Cocaine-induced c-fos messenger RNA is inversely related to dynorphin expression in striatum. J Neurosci 1993; 13: 5066-5081.
268. Steiner H, Gerfen CR. Dynorphin opioid inhibition of cocaine-induced D1 dopamine receptor-mediated immediate-early gene expression in the striatum. J Comp Neurol 1995; 353:200-212.
269. Stornetta RL, Norton FE, Guyenet PG. Autonomic areas of rat brain increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res 1993; 624: 19-28.
270. Staaten FV, Muller R, Curran T, Van Beveren C, Verma IM. Complete nucleotide sequence of a human c-onc gene: Deduced amino acid sequence of the human c-fos protein. Proc Natl Acad Sci USA 1983; 80: 3183-3187.
271. Strassman AM, Mineta Y, Vos BP. Distribution of Fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of durai blood vessels in the rat. J Neurosci 1994; 14: 3725-3735.
272. Struhl K. Helix-turn-helix, zinc finger, and leucine-zipper motifs for eukaryotic transcriptional regulatory proteins. Trends Biochem Sci 1989; 14: 137-140.
273. Struhl K. Mechanisms for diversity in gene expression patterns. Neuron 1991; 7: 177-181.
274. Sukhatme VP, Cao X, Chang LC, Tsai-Morris CH, Stamenkovich D, Ferreira PCP, Cohen DR, Edwards SA, Shows TB, Curran T, Le Beau MM, Adamson ED. A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 1988; 53: 37-43.
275. Sutherland JA, Cook A, Bannister AJ, Kouzarides T. Conserved motifs in Fos and Jun define a new class of activation domain. Genes Dev 1992; 6: 1810-1819.
276. Tache Y, Du Ruisseau P, Tache J, Selye H, Collu R. Shift in adenohypophyseal activity during chronic intermittent immobilization in rats. Neuroendocrinology 1976; 22: 325-336.
277. Talmage DA, Listerud M. Retinoic acid suppresses polyoma virus transformation by inhibiting transcription of the c-fos proto-oncogene. Oncogene 1994; 9: 3557-3563.
278. Taylor LK, Marshak DR, Landreth GE. Identification of a nerve-growth factor- and epidermal growth factor-regulated protein kinase that phosphorylates the protooncogene product c-Fos. Proc Natl Acad Sci USA 1993; 90: 368-372.
279. Terry P. Differential effects of injection regimen on behavioral responses to cocaine. Pharmacol Biochem Behav 1992; 41: 365-369.
280. Torres G, Rivier C. Differential effects of intermittent or continuous exposure to cocaine on the hypothalamic-pituitary-adrenal axis and c-fos expression. Brain Res 1992; 571: 204-211.
281. Torres G, Rivier C. Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists. Brain Res Bull 1993; 30: 173-176.
282. Torres G, Rivier C. Induction of c-fos in rat brain by acute cocaine and fenfluramine exposure: a comparison study. Brain Res 1994; 647: 1-9.
283. Torres G. Acute administration of alcohol blocks cocaine-induced striatal c-fos immunoreactivity protein in the rat. Synapse 1994; 18: 161-167.
284. Touray M, Ryan F, Jaggi R, Martin F. Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun. Oncogene 1991; 1227-1234.
285. Treacy MN, Rosenfeld MG. Expression of a family of POU-domain protein regulatory genes during development of the central nervous system. Ann Rev Neurosci 1992; 15: 139-165.
286. Trejo J, Chambard JC, Karin M, Brown JH. Biphasic increase in c-jun mRNA is required for induction of AP-1-mediated gene transcription: differential effects of muscarinic and thrombin receptor activation. Mol Cell Biol 1992; 12: 4742-4750.
287. Tsai SY, Caristedt-Duke J, Weigel NL, Dahlman K, Gustafsson JA, Tsai MJ, O'Malley BW. Molecular interactions of steroid hormone receptor with its enhancer element: evidence for receptor dimer formation. Cell 1988; 55: 361-369.
288. Uhl GR, Appleby DA, Nishimori TN. Regulated expression of transcription factor and neurotransmitter genes in neural populations: studies using in situ hybridization with radiolabelled oligonucleotide probes. In: Calas A, Eugene D, eds, Neurocytochemical Methods, NATO ASI Series Vol H58. Berlin: Springer-Verlag, 1991; 137-142.
289. Uhl GR, Walther D, Nishimori T, Buzzi MG, Moskowitz A. Jun-B, c-jun, jun-D and c-fos mRNAs in nucleus caudalis: rapid selective enhancement by afferent stimulation. Mol Brain Res 1991; 11: 133-141.
290. Uhl GR, Nishimori T. Neuropeptide gene expression and neural activity: assessing a working hypothesis in nucleus caudalis and dorsal horn neurons expressing preproenkephalin and preprodynorphin. Cell Mol Neurobiol 1990; 10: 73-98.
291. Unlap T, Jope RS. Diurnal variation in kainate-induced AP-1 activation in rat brain: influence of glucocorticoids. Mol Brain Res 1995: 28: 193-200.
292. Van den Bergh S, Kaina B, Rahmsdorf HJ, Ponta H, Herrlich P. Involvement of fos in spontaneous and ultraviolet light-induced genetic changes. Mol Carcinogenesis 1991; 4: 460-466.
293. Van der Loos H, Woolsey TA. Somatosensory cortex: structural alterations following early injury to sense organs. Science 1973: 179: 395-398.
294. Virgo L, de Belleroche J. Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA. Brain Res 1995; 676: 196-204.
295. Volkow ND, Fowler JS, Wolf AP, Hitzemann R, Dewey S, Bendriem B, Alpert R, Hoff A. Changes in brain glucose metabolism in cocaine dependence and withdrawal. Am J Psychiatry 1991; 148: 621-626.
296. Volkow ND. Hitzemann R, Wang GJ, Fowler JS, Wolf AP, Dewey SL, Handlesman L. Long-term frontal brain metabolic changes in cocaine abusers. Synapse 1992; 11: 184-190.
297. Vriz S, Lemaitre JM, Leibovici M, Thierry N, Mechali M. Comparative analysis of the intracellular localization of c-Myc, c-Fos, and replicative proteins during cell cycle progression. Mol Cell Biol 1992; 12: 3548-3555.
298. Xanthoudakis S, Miao G, Wang F, Pan YCE, Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 1992; 11: 3323-3335.
299. Wahlestedt C. Antisense oligonucleotide strategies in neuropharmacology. Trends Pharmacol Sci 1994; 15: 42-46.
300. Wang JQ, McGinty JF. Alterations in striatal zif/268, preprodynorphin and preproenkephalin mRNA expression induced by repeated amphetamine administration in rats. Brain Res 1995; 673: 262-274.
301. Watson R, Hartmann E, Schildkraut JJ. Amphetamine withdrawal: affective state, sleep patterns, and MHPG excretion. Am J Psychiatry 1972; 129: 39-45.
302. Weaver DR, Roca AL, Reppert SM. c-fos and jun-B mRNAs are transiently expressed in fetal rodent suprachiasmatic nucleus following dopaminergic stimulation. Dev Brain Res 1995; 85: 293-297.
303. Weiser M, Baker H, Wessel TC, Joh TH. Differential spatial and temporal gene expression in response to axotomy and deafferentation following transection of the medial forebrain bundle. J Neurosci 1993; 13: 3472-3484.
304. Wellington CL, Greenberg ME, Belasco JG. The destabilizing elements in the coding region of c-fos mRNA are recognized as RNA. Mol Cell Biol 1993; 13: 5034-5042.
305. Widnell KL, Russell DS, Nestler EJ. Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proc Natl Acad Sci USA 1994; 91: 10947-10951.
306. Wilke N, Sganga M, Barhite S, Miles MF. Effects of alcohol on gene expression in neural cells. In: Jansson B, Jomvall H, Rydbcrg U, Terenius L, Vallee BL, eds, Toward a Molecular Basis of Alcohol Use and Abuse. Basel: Birkhauser Verlag, 1994; 49-59.
307. Williams J, Dragunow M, Lawlor P, Mason S, Abraham WC, Leah J, Bravo R, Demmer J, Tate W. Krox20 may play a key role in the stabilization of long-term potentiation. Mol Brain Res 1995; 28: 87-93.
308. Williams T, Admon A, Luscher B, Tjian R. Cloning and expression of AP-2, a cell-type-specific transcription factor that activates inducible enhancer elements. Genes Dev 1988; 2: 1557-1569.
309. Willner P. Animal models of depression: an overview. Pharmac Ther 1990; 45: 425-455.
310. Willner P, Sampson D, Papp M, Phillips G, Muscat R. Animal models of anhedonia. In: Simon P, Soubrie P, Widlocher D, eds, Animal Models of Psychiatric Disorders Vol 3. Basel: Karger, 1990; 71-99.
311. Wilson TC, Treisman R. Fos C-terminal mutations block down-regulation of c-fos transcription following serum stimulation. EMBO J 1988; 7: 4193-4202.
312. Wilson TE, Day ML, Pexton T, Padgett KA, Johnston M, Milbrandt J. In vivo mutational analysis of the NGFI-A zinc fingers. J Biol Chem 1992; 267: 3718-3724.
313. Winston SM, Hayward MD, Nestler EJ, Duman RS. Chronic electroconvulsive seizures down-regulate expression of the immediate-early genes c-fos and c-jun in rat cerebral cortex. J Neurochem 1990; 54: 1920-1925.
314. Wisden W, Errington ML, Williams S, Dunnett SB, Waters C, Hitchcock D, Evan G, Bliss TVP, Hunt SP. Differential expression of immediate early genes in the hippocampus and spinal cord. Neuron 1990; 4: 603-614.
315. Wollnik F, Brysch W, Uhlmann E, Gillardon F, Bravo R, Zimmermann M, Schlingensiepen KH, Herdegen T. Block of c-Fos and JunB expression by antisense oligonucleotides inhibits light-induced phase shifts of the mammalian circadian clock. Eur J Neurosci 1995; 7: 388-393.
316. Woolsey TA, Van der Loos H. The structural organization of layer IV in the somatosensory region (SI) of mouse cerebral cortex. The description of a cortical field composed of discrete cytoarchitectonic units. Brain Res 1970; 17: 205-242.
317. Woolsey TA, Wann JR. Areal changes in mouse cortical barrels following vibrissal damage at different postnatal ages. J Comp Neurol 1976; 170: 53-66.
318. Wooten GF, DiStefano P, Collins RC. Regional cerebral glucose utilization during morphine withdrawal in the rat. Proc Natl Acad Sci USA 1982; 79: 3360-3364.
319. Workman JL, Buchman AR. Multiple functions of nucleosomes and regulatory factors in transcription. Trends Genet 1993; 9: 90-95.
320. Worley PF, Christy BA, Nakabeppu Y, Bhat RV, Cole AJ, Baraban JM. Constitutive expression of zif268 in neocortex is regulated by synaptic activity. Proc Natl Acad Sci USA 1991; 88: 5106-5110.
321. Worley PF, Bhat RV, Baraban JM, Erickson CA, McNaughton BL, Barnes C. Thresholds for synaptic activation of transcription factors in hippocampus: correlation with long-term enhancement. J Neurosci 1993; 13: 4776-4786.
322. Wrighton C, Busslinger M. Direct transcriptional stimulation of the ornithine decarboxylase gene by c-fos in PC12 cells but not in fibroblasts. Mol Cell Biol 1993; 13: 4657-4669.
323. Yamamoto KK, Gonzalez GA, Biggs WH III, Montminy MR. Phosphorylation-induced binding and transcriptional efficiency of nuclear factor CREB. Nature 1988; 334: 494-498.
324. Yen J, Wisdom RM, Tratner I, Verma IM. An Alternatively spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc Natl Acad Sci USA 1991; 88: 5077-5081.
325. Yin JCP, Wallach JS, Del Vecchio M, Wilder EL, Zhou H, Quinn WG, Tully T. Induction of a dominant negative CREB transgene specifically blocks long-term memory in Drosophila. Cell 1994; 79: 49-58.
326. 1 receptors. Proc Natl Acad Sci USA 1991; 88: 1291-1295.
327. Yuguchi T, Kohmura E, Yamada K, Sakaki T, Yamashita T, Otsuki H, Wanaka A, Tohyama M, Tsuji S, Hayakawa T. Changes in growth inhibitory factor mRNA expression compared with those in c-jun mRNA expression following facial nerve transection. Mol Brain Res 1995; 28: 181-185.
328. Zerial M, Toschi L, Ryseck RP, Schuermann M, Muller R, Bravo R. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J 1989; 8: 805-813.
329. Zhu QS, Chen K, Shih JC. Bidirectional promoter of human monoamine oxidase A (MAO A) controlled by transcription factor Sp1. J Neurosci 1994; 14: 7393-7403.
330. Zoeller RT, Fletcher DL. A single administration of ethanol simultaneously increases c-fos mRNA and reduces c-jun mRNA in the hypothalamus and hippocampus. Mol Brain Res 1994; 24: 185-191.